Cargando…
A workflow for the joint modeling of longitudinal and event data in the development of therapeutics: Tools, statistical methods, and diagnostics
Clinical trials investigate treatment endpoints that usually include measurements of pharmacodynamic and efficacy biomarkers in early‐phase studies and patient‐reported outcomes as well as event risks or rates in late‐phase studies. In recent years, a systematic trend in clinical trial data analytic...
Autores principales: | Zhudenkov, Kirill, Gavrilov, Sergey, Sofronova, Alina, Stepanov, Oleg, Kudryashova, Nataliya, Helmlinger, Gabriel, Peskov, Kirill |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9007602/ https://www.ncbi.nlm.nih.gov/pubmed/35064957 http://dx.doi.org/10.1002/psp4.12763 |
Ejemplares similares
-
Longitudinal FEV(1) and Exacerbation Risk in COPD: Quantifying the Association Using Joint Modelling
por: Zhudenkov, Kirill, et al.
Publicado: (2021) -
Longitudinal Tumor Size and Neutrophil‐to‐Lymphocyte Ratio Are Prognostic Biomarkers for Overall Survival in Patients With Advanced Non‐Small Cell Lung Cancer Treated With Durvalumab
por: Gavrilov, Sergey, et al.
Publicado: (2020) -
Interpretation of metabolic memory phenomenon using a physiological systems model: What drives oxidative stress following glucose normalization?
por: Voronova, Veronika, et al.
Publicado: (2017) -
A Six‐Stage Workflow for Robust Application of Systems Pharmacology
por: Gadkar, K, et al.
Publicado: (2016) -
Efficient Pharmacokinetic Modeling Workflow With the MonolixSuite: A Case Study of Remifentanil
por: Traynard, Pauline, et al.
Publicado: (2020)